Garsorasib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Garsorasib, covering 2025-12-19 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study) [Phase 2]